** Shares of Medical Developments International MVP.AX rise as much as 12% to A$0.700, its biggest intraday gain since August 5

** The pharmaceuticals company says group revenue for Q1 FY26 was A$10.9 million ($7.14 million), up A$1.9 million on pcp

** Stock hits highest level since October 2

** MVP currently up 10.4%, bringing YTD gains to 54.3%

($1 = 1.5260 Australian dollars)

(Reporting by Adwitiya Srivastava in Bengaluru)

((Adwitiya.Srivastava@thomsonreuters.com))